President Donald Trump talked up a joint venture investing up to $500 billion for infrastructure tied to AI by a new partnership formed by OpenAI, Oracle and SoftBank.
SoftBank Group Corp., OpenAI, and Oracle Corp. are forming a $100 billion joint venture to fund artificial intelligence infrastructure, an effort unveiled with President Donald Trump aimed at speeding development of the emerging technology.
Larry Ellison unveiled plans for an AI-driven cancer vaccine system that could deliver personalized treatments within 48 hours.
The $500 billion Stargate Initiative — led by Trump, OpenAI, SoftBank, and Oracle — is set to revolutionize U.S. AI infrastructure.
Masayoshi Son of SoftBank, Sam Altman of OpenAI and Larry Ellison of Oracle joined Trump for the $500 billion announcement.
SOFTBANK Group and OpenAI each plan to commit US$19 billion of capital ... SoftBank’s Masayoshi Son, OpenAI’s Altman and Oracle’s Larry Ellison took the wraps off Stargate this week at the White House, saying they would deploy US$100 billion for ...
Masayoshi Son, SoftBank Group CEO, from left, Larry Ellison, chairman of Oracle Corporation and chief technology officer, and Sam Altman, OpenAI CEO listen to President Donald Trump in the ...
(Bloomberg) -- SoftBank Group Corp., OpenAI ... OpenAI’s Sam Altman and Oracle’s Larry Ellison. The joint venture will deploy $100 billion “immediately” and have a goal of increasing ...
During a press conference on Tuesday afternoon, President Donald Trump floated the idea of Elon Musk or Larry Ellison purchasing TikTok, while also proposing that the U.S. government take a significant share of the transaction.
SoftBank, OpenAI, and Oracle are launching a $500 billion joint venture named Stargate to fund AI infrastructure in the U.S. The initiative, praised by President Trump, aims to deploy $100 billion immediately for projects like data centers and cancer research.
Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the development of a cancer vaccine.